DPW
CYTK icon

DiNuzzo Private Wealth’s Cytokinetics CYTK Stock Holding History

DiNuzzo Private Wealth’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341 Buy
4
+3
+300% +$215 ﹤0.01% 1183
2026
Q1 		$66 Buy
+1
New +$64 ﹤0.01% 1298
2024
Q4 		– Sell
-15
Closed -$792 – 1425
2024
Q3 		$792 Buy
15
+7
+88% +$390 ﹤0.01% 950
2024
Q2 		$434 Buy
+8
New +$483 ﹤0.01% 1084

Other funds holding CYTK

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

DiNuzzo Private Wealth's CYTK Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its Cytokinetics (CYTK) stake by 300% in Q2 2026, buying an estimated $215 and bringing the position to 4 shares worth $341. The position accounts for ﹤0.01% of the portfolio, ranked #1183.

DiNuzzo Private Wealth first reported a position in CYTK in Q2 2024 and has held it in 4 quarters since. The position peaked at $792 in Q3 2024. 92 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • DiNuzzo Private Wealth held 4 shares of Cytokinetics worth $341 as of Q2 2026.
  • DiNuzzo Private Wealth bought 3 Cytokinetics shares in Q2 2026, an estimated $215.
  • Cytokinetics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1183 holding.
  • DiNuzzo Private Wealth first reported a position in Cytokinetics in Q2 2024 and has held it in 4 quarters since.
  • DiNuzzo Private Wealth's Cytokinetics position peaked at $792 in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.